Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of 280.31 billion as of January 7, 2026. Its market cap has decreased by -2.55% in one year.

Market Cap

280.31B

Enterprise Value

226.41B

Revenue

49.40B

Ranking

n/a

PE Ratio

17.66

Stock Price

736.90

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 227.80M to 280.31B, an increase of 122,948.64%. That is a compound annual growth rate of 23.67%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	268.04B	0.61%
Dec 31, 2025	266.42B	-7.83%
Dec 31, 2024	289.05B	-16.66%
Dec 29, 2023	346.85B	18.17%
Dec 30, 2022	293.52B	11.36%
Dec 31, 2021	263.57B	42.98%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Banco de Crédito del Perú	73.95B
Sociedad Minera Cerro Verde	57.67B
Unión de Cervecerías Peruanas Backus y Johnston	28.18B
Compañía de Minas Buenaventura	24.42B
Banco BBVA Perú	17.47B
Minsur	16.14B
Intercorp Financial Services	15.77B
Shougang Hierro Peru S.a.a.	10.71B

Market Cap Rankings